Dr Clara Orofino Peña

Managing IP's Rising Stars 2021

Star-shaped oligofluorene truxene macromolecules – synthesis and properties as a function of alkyl chain length

A saturated red color converter for visible light communication using a blend of star-shaped organic semiconductors

Fluorene-containing tetraphenylethylene molecules as lasing materials

Fluorescent Red-Emitting BODIPY Oligofluorene Star-Shaped Molecules as a Color Converter Material for Visible Light Communications

Location, Location, Location - Strategic Positioning of 2,1,3-Benzothiadiazole Units within Trigonal Quaterfluorene-Truxene Star-Shaped Structures

Mechanically Flexible Organic Semiconductor Laser Array

A saturated red color converter for visible light communication using a blend of star-shaped organic semiconductors

BODIPY star-shaped molecules as solid state colour converters for visible light communications

CSR

Clara has mentored trainees on drafting and prosecution matters and has delivered tutorials for the EQE paper B.

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Basics of trade mark protection - National and European perspectives

HGF is pleased to invite you to our upcoming German speaking seminar on “Fundamentals of trade mark protection: National and European Perspectives” in Salzburg and Dresden. The seminar will cover …

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’ for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …